Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$820M |
| 2 |
Palo Alto Networks
PANW
|
+$358M |
| 3 |
Visa
V
|
+$355M |
| 4 |
CELG
Celgene Corp
CELG
|
+$339M |
| 5 |
Citigroup
C
|
+$325M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$722M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
+$356M |
| 3 |
Alibaba
BABA
|
+$345M |
| 4 |
EOG Resources
EOG
|
+$344M |
| 5 |
Canadian Pacific Kansas City
CP
|
+$321M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.08% |
| 2 | Consumer Discretionary | 17.25% |
| 3 | Communication Services | 14.3% |
| 4 | Technology | 13.13% |
| 5 | Financials | 9.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
576
Gartner
IT
$11.1B
| $2.92M | ﹤0.01% |
34,740
| – | – |
|
577
Danaher
DHR
$138B
| $2.88M | ﹤0.01% |
+50,292
| New | +$2.97M |
|
578
Enbridge
ENB
$120B
| $2.86M | ﹤0.01% |
76,922
-9,965
| -11% | -$416K |
|
579
Baxter International
BAX
$12.8B
| $2.84M | ﹤0.01% |
+86,497
| New | +$3.27M |
|
|
ITC
580
DELISTED
ITC HOLDINGS CORP
ITC
| $2.83M | ﹤0.01% |
+84,841
| New | +$2.83M |
|
581
Keurig Dr Pepper
KDP
$42.8B
| $2.65M | ﹤0.01% |
33,523
+1,101
| +3% | +$86.3K |
|
|
RRMS
582
DELISTED
ROSE ROCK MIDSTREAM L P COM UNIT REPSTG LTD (DE)
RRMS
| $2.65M | ﹤0.01% |
108,759
+28,532
| +36% | +$994K |
|
583
Penumbra
PEN
$12.6B
| $2.61M | ﹤0.01% |
+65,000
| New | +$2.63M |
|
584
Altria Group
MO
$125B
| $2.58M | ﹤0.01% |
47,494
+129
| +0.3% | +$6.92K |
|
585
Lamar Advertising Co
LAMR
$16.7B
| $2.56M | ﹤0.01% |
+49,136
| New | +$2.75M |
|
|
EQM
586
DELISTED
EQM Midstream Partners, LP
EQM
| $2.54M | ﹤0.01% |
38,328
-270,047
| -88% | -$20.4M |
|
|
WNRL
587
DELISTED
Western Refining Logistics, LP
WNRL
| $2.5M | ﹤0.01% |
119,887
+26,050
| +28% | +$655K |
|
|
IMDZ
588
DELISTED
Immune Design Corp.
IMDZ
| $2.47M | ﹤0.01% |
202,683
+1,224
| +0.6% | +$22.9K |
|
|
WPZ
589
DELISTED
Williams Partners L.P.
WPZ
| $2.37M | ﹤0.01% |
74,117
-23,851
| -24% | -$998K |
|
|
RVNC
590
DELISTED
Revance Therapeutics, Inc.
RVNC
| $2.33M | ﹤0.01% |
78,156
+603
| +0.8% | +$18.3K |
|
|
MRTX
591
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $2.24M | ﹤0.01% |
+65,000
| New | +$1.96M |
|
592
Sunoco
SUN
$14.4B
| $2.14M | ﹤0.01% |
63,113
-28,467
| -31% | -$1.09M |
|
593
PACCAR
PCAR
$70.5B
| $2.13M | ﹤0.01% |
+61,362
| New | +$2.49M |
|
594
Lennar Class A
LEN
$20.4B
| $2.07M | ﹤0.01% |
45,217
-3,721
| -8% | -$183K |
|
595
The Mosaic Company
MOS
$7.19B
| $2.06M | ﹤0.01% |
+66,120
| New | +$2.73M |
|
596
Macy's
M
$6.51B
| $2.02M | ﹤0.01% |
39,399
+27,057
| +219% | +$1.7M |
|
597
Fulton Financial
FULT
$4.68B
| $1.98M | ﹤0.01% |
163,958
+5,379
| +3% | +$67.8K |
|
598
Enterprise Products Partners
EPD
$83.7B
| $1.97M | ﹤0.01% |
79,257
+6,969
| +10% | +$193K |
|
|
BWP
599
DELISTED
Boardwalk Pipeline Partners
BWP
| $1.97M | ﹤0.01% |
+167,159
| New | +$2.28M |
|
|
DST
600
DELISTED
DST Systems Inc.
DST
| $1.94M | ﹤0.01% |
36,856
-330
| -0.9% | -$18.3K |
|
Similar funds
Jennison Associates's Q3 2015 Portfolio in Review
As of Q3 2015, Jennison Associates held 813 positions worth $97.6B, down 11% from $109B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Jennison Associates's Q3 2015 filing shows 84 new, 272 increased, 353 reduced and 92 closed positions. Its largest new stake was Palo Alto Networks: 12,124,434 shares worth $348M. The largest sale was Gilead Sciences, an estimated $722M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Communication Services.
- Jennison Associates's largest Q3 2015 buy was Palo Alto Networks: 12,124,434 shares worth $348M.
- Jennison Associates added most to Alphabet (Google) Class C in Q3 2015, an estimated $820M increase.
- Jennison Associates's biggest Q3 2015 reduction was Gilead Sciences, cutting an estimated $722M.
- Jennison Associates fully exited KRAFT FOODS GROUP INC COM STK (VA) in Q3 2015, selling an estimated $144M.
- Jennison Associates's ten largest holdings make up 24% of its $97.6B portfolio in Q3 2015.
- Jennison Associates opened 84 new positions and closed 92 in Q3 2015.
- Jennison Associates's portfolio value fell 11% quarter-over-quarter to $97.6B.
Based on Jennison Associates's 13F filing for Q3 2015, filed 6 Nov 2015.